
This is a promotional website intended for UK healthcare professionals.
Colobreathe® (colistimethate sodium) Prescribing Information can be found here.
Adverse Event Reporting Information can be found at the end of this page.
This privacy notice is issued on behalf of Essential Pharma Limited, 8A Crabtree Road, Egham, Surrey, TW20 8RN, United Kingdom, company number 07514667, which is part of the Essential Pharma group of companies. When we use the terms "Essential Pharma", "we", "us” or “our" in this Privacy Notice, we are referring to the company that is responsible for processing your Personal Information. In this capacity we are a data "Controller", which means we are responsible for determining how we hold and use Personal Information about you.
Personal Information is information that can be used to identify you or another living person, for example your name, birth date, e-mail address, mailing address, or telephone number.
We only collect and process your Personal Information in accordance with applicable laws.
We receive Personal Information directly from you when you access our Website and when you voluntarily complete and submit the form in the Contact Us section.
We process the contact details you provide directly to us such as your name and your email address or telephone number when you consent to us doing so via our Website. Your consent allows us to communicate with you and respond to your query appropriately.
Each time you visit our Website we may also automatically collect information and personal data about your computer for system administration including, where available, your IP address, operating system and browser type. We do this to help us identify returning visitors, enable visitors to move more easily around our Website, and to assist in building up an anonymous profile based on visitor’s browsing patterns across the sites. Please see our Cookie Policy for further information.
You do not have to provide your personal data to us. However, if you fail to provide certain information when requested, we will not be able to contact you to respond to your query.
We will not sell, share, or otherwise distribute your Personal Information to third parties for marketing purposes.
We may share your Personal Information within the Essential Pharma group to allow administrators, and other selected staff to perform their respective functions and respond to your initial query or any subsequent queries appropriately.
Your Personal Information may also be transferred to third parties who act for or on our behalf, for further processing in accordance with the purpose(s) for which the data were originally collected (stated above) or may otherwise be lawfully processed.
These third parties include:
We don’t routinely transfer your Personal Information overseas and where we do need to transfer your data outside of the UK, Switzerland or the EEA, we will ensure that the appropriate safeguards are in place. Please contact us (see the last section of this notice) if you would like more details on transfer mechanisms.
We take the security of your data seriously. We implement appropriate technical and organisational measures to protect your Personal Information from unauthorised access, alteration, disclosure, destruction or deletion. More information about these measures can be obtained by contacting us (see the last section of this notice).
Those processing your Personal Information will do so only in an authorised manner and are subject to a duty of confidentiality.
We will only retain your Personal Information for as long as is reasonably necessary. Therefore, the duration will vary between different types of information. When we consider our approach we assess any ongoing need for the information, as well as our legal obligations for example in relation to tax, health and safety, employment rights and potential or actual disputes or investigations.
Under data protection law, you have rights including:
You also have the right to withdraw consent at any time where we are relying on consent to process your Personal Information. This will not affect the lawfulness of any processing carried out before you withdraw your consent. If withdrawal of your consent means that we are not able to provide certain products or services to you, we will advise you that this is the case.
If you have any questions or concerns about your Personal Information or our Privacy Notice, or to exercise your rights, please contact our Data Protection Lead by emailing compliance@essentialpharmagroup.com or write to us at 8A Crabtree Road, Egham, Surrey, TW20 8RN, UK.
You also have the right to lodge a complaint with a Supervisory Authority for data protection. For the UK and countries within the EU, you can find the name and contact details of the relevant body by visiting https://ec.europa.eu/justice/article-29/structure/data-protection-authorities/index_en.htm.
We take our obligations seriously, therefore if you have any questions or concerns, we would encourage you to raise them with us first, so that we can try to resolve them.
This notice was last reviewed and updated in May 2025.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for the MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Essential Pharma on +44 (0) 1423 850700 or at EssentialpharmaUK@EU.ProPharmaGroup.com.
Essential Pharma Ltd, 8A Crabtree Road, Egham, Surrey, TW20 8RN, United Kingdom
Colobreathe® is a registered trademark of Essential Pharma. Copyright © 2026 Essential Pharma
MAT-COL-GB-0004-0125 May 2025
